Todd Bazemore

Director/Board Member at PULMATRIX, INC.

Net worth: 647 $ as of 2026-05-30

55 year

30 connections

Health Technology

Consumer Services

Commercial Services

Profile

Todd Bazemore is President, Chief Executive Officer & Director at Airna, Inc. since 2026.
Mr. Bazemore is Independent Director at Pulmatrix, Inc. since 2020.
Former positions include Director at Kala Bio, Inc. from 2025 to 2026; Vice President-Managed Markets at Sumitomo Pharma America, Inc. from 2012 to 2013; Chief Commercial Officer & Executive Vice President at Dyax Corp.
from 2014 to 2016; Chief Operating Officer & Executive Vice President at Santhera Pharmaceuticals Holding AG from 2016 to 2017; and Chief Operating Officer & Executive Vice President at Santhera Pharmaceuticals (USA), Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Massachusetts Lowell.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
KALA BIO, INC. 0%	2025-12-28	290 ( 0% )	647 $	2026-05-30
PULMATRIX INC -.--%	2026-02-22	0 ( -.--% )	- $	2026-05-30

Todd Bazemore active positions

Companies	Position	Start
PULMATRIX, INC.	Director/Board Member	2020-09-30
Airna, Inc. Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics	Chief Executive Officer	2026-06-01

All active positions of Todd Bazemore

Former positions of Todd Bazemore

Companies	Position	End
KALA BIO, INC.	Chief Executive Officer	2025-11-22
SANTHERA PHARMACEUTICALS HOLDING AG	Chief Operating Officer	2017-10-31
Santhera Pharmaceuticals (USA), Inc. Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs	Chief Operating Officer	2017-10-31
DYAX CORP.	Corporate Officer/Principal	2016-01-21
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Corporate Officer/Principal	2013-08-31

See the detail of Todd Bazemore's experience

Training of Todd Bazemore

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Todd Bazemore's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Health Technology
Dyax Corp. Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics	Health Technology
Kala Bio, Inc. Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies	Health Technology
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases	Health Technology
University of Massachusetts Lowell University of Massachusetts Lowell Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pulmatrix, Inc. Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease	Health Technology
Santhera Pharmaceuticals (USA), Inc. Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs	Health Technology
Airna, Inc. Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics	Commercial Services